Money & MarketsCovid-19 meant women worked an extra 173 hours without pay in 2020Updated July 20, 2022
Money & MarketsBuying all of the US’s medical debt would cost less than $3 a personUpdated July 20, 2022
Tech & InnovationDuring the pandemic, nearly half of all US crowdfunding campaigns raised $0Updated July 20, 2022
Money & MarketsThe origins of Covid-19’s racial disparities lie in America’s prisonsUpdated July 20, 2022
Tech & InnovationER visits in the US plunged in the pandemic, and that’s not goodUpdated July 20, 2022
Tech & InnovationPhiladelphia is offering extreme vaccine incentives with help from Wharton economistsUpdated July 20, 2022
Money & MarketsPoor countries will have to wait for Covid-19 vaccine leftovers until 2023Updated July 20, 2022
Tech & InnovationTelehealth fraud has cheated the US of billions in the pandemicUpdated July 20, 2022
Money & MarketsThe Jesuits’ plan to compensate their slaves’ descendants gets reparation wrongUpdated July 20, 2022
Money & MarketsBig pharma wants you to think sharing vaccine patents overseas is very dangerousUpdated July 20, 2022
Money & MarketsIndia’s at-home Covid test is priced out of reach for most IndiansUpdated July 20, 2022
Tech & InnovationInvestors are starting to appreciate the business potential of vaccinesUpdated July 20, 2022
Tech & InnovationThe founder of Moderna doesn’t think vaccines are all that impressiveUpdated July 20, 2022
Money & MarketsThe Indian diaspora is struggling to help with the Covid-19 crisis in IndiaUpdated July 20, 2022
Money & MarketsChauvin prosecutor Keith Ellison makes a powerful call for “the work of our generation”Updated July 20, 2022
